Locally Advanced Malignant Solid Neoplasm clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2
Sorry, in progress, not accepting new patients
This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have spread to other places in the body (advanced/metastatic). Adavosertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Orange, California and other locations

Last updated: August 2024